Principal Financial Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.1M | Buy |
430,558
+53,990
| +14% | +$419K | ﹤0.01% | 1682 |
|
|
2025
Q4 | $2.94M | Buy |
376,568
+132,159
| +54% | +$955K | ﹤0.01% | 1768 |
|
|
2025
Q3 | $1.86M | Buy |
244,409
+56,213
| +30% | +$468K | ﹤0.01% | 1827 |
|
|
2025
Q2 | $1.69M | Buy |
188,196
+171,701
| +1,041% | +$1.6M | ﹤0.01% | 1823 |
|
|
2025
Q1 | $124K | Sell |
16,495
-1,312
| -7% | -$10.6K | ﹤0.01% | 2087 |
|
|
2024
Q4 | $134K | Sell |
17,807
-393,607
| -96% | -$2.99M | ﹤0.01% | 2133 |
|
|
2024
Q3 | $3.13M | Buy |
411,414
+375,890
| +1,058% | +$2.86M | ﹤0.01% | 1692 |
|
|
2024
Q2 | $220K | Sell |
35,524
-12,691
| -26% | -$70K | ﹤0.01% | 2125 |
|
|
2024
Q1 | $245K | Buy |
48,215
+216
| +0.5% | +$1.22K | ﹤0.01% | 2137 |
|
|
2023
Q4 | $288K | Sell |
47,999
-679
| -1% | -$3.94K | ﹤0.01% | 2075 |
|
|
2023
Q3 | $345K | Buy |
48,678
+1,120
| +2% | +$8.05K | ﹤0.01% | 2024 |
|
|
2023
Q2 | $335K | Buy |
47,558
+353
| +0.7% | +$2.83K | ﹤0.01% | 2047 |
|
|
2023
Q1 | $394K | Buy |
47,205
+384
| +0.8% | +$3.7K | ﹤0.01% | 2028 |
|
|
2022
Q4 | $538K | Sell |
46,821
-55,845
| -54% | -$696K | ﹤0.01% | 1960 |
|
|
2022
Q3 | $1.29M | Sell |
102,666
-96,743
| -49% | -$1.24M | ﹤0.01% | 1797 |
|
|
2022
Q2 | $2.11M | Buy |
199,409
+162,417
| +439% | +$1.68M | ﹤0.01% | 1790 |
|
|
2022
Q1 | $601K | Sell |
36,992
-1,509
| -4% | -$24.2K | ﹤0.01% | 2078 |
|
|
2021
Q4 | $534K | Sell |
38,501
-15,012
| -28% | -$199K | ﹤0.01% | 2106 |
|
|
2021
Q3 | $769K | Sell |
53,513
-8,571
| -14% | -$135K | ﹤0.01% | 2068 |
|
|
2021
Q2 | $981K | Sell |
62,084
-10,657
| -15% | -$145K | ﹤0.01% | 2045 |
|
|
2021
Q1 | $740K | Sell |
72,741
-2,039
| -3% | -$21K | ﹤0.01% | 2057 |
|
|
2020
Q4 | $557K | Buy |
74,780
+19,816
| +36% | +$102K | ﹤0.01% | 2086 |
|
|
2020
Q3 | $189K | Sell |
54,964
-1,734
| -3% | -$7.43K | ﹤0.01% | 2216 |
|
|
2020
Q2 | $270K | Buy |
56,698
+23,824
| +72% | +$95.1K | ﹤0.01% | 2110 |
|
|
2020
Q1 | $66K | Buy |
32,874
+1,409
| +4% | +$3.88K | ﹤0.01% | 2144 |
|
|
2019
Q4 | $109K | Sell |
31,465
-1,679
| -5% | -$4.22K | ﹤0.01% | 2182 |
|
|
2019
Q3 | $95K | Buy |
33,144
+3,391
| +11% | +$10.5K | ﹤0.01% | 2182 |
|
|
2019
Q2 | $113K | Sell |
29,753
-1,284
| -4% | -$7.73K | ﹤0.01% | 2174 |
|
|
2019
Q1 | $253K | Buy |
31,037
+857
| +3% | +$7.34K | ﹤0.01% | 2078 |
|
|
2018
Q4 | $244K | Buy |
30,180
+12,400
| +70% | +$96.4K | ﹤0.01% | 2083 |
|
|
2018
Q3 | $136K | Sell |
17,780
-11,180
| -39% | -$75.1K | ﹤0.01% | 2210 |
|
|
2018
Q2 | $166K | Buy |
28,960
+1,482
| +5% | +$8.16K | ﹤0.01% | 2182 |
|
|
2018
Q1 | $131K | Buy |
27,478
+2,285
| +9% | +$11.7K | ﹤0.01% | 2140 |
|
|
2017
Q4 | $124K | Buy |
25,193
+13,154
| +109% | +$63.7K | ﹤0.01% | 2172 |
|
|
2017
Q3 | $63K | Sell |
12,039
-2,336
| -16% | -$12K | ﹤0.01% | 2161 |
|
|
2017
Q2 | $80K | Buy |
14,375
+1,125
| +8% | +$6.85K | ﹤0.01% | 2206 |
|
|
2017
Q1 | $111K | Buy |
13,250
+45
| +0.3% | +$313 | ﹤0.01% | 2138 |
|
|
2016
Q4 | $84K | Hold |
13,205
| – | – | ﹤0.01% | 2172 |
|
|
2016
Q3 | $58K | Buy |
13,205
+566
| +4% | +$2.26K | ﹤0.01% | 2132 |
|
|
2016
Q2 | $36K | Hold |
12,639
| – | – | ﹤0.01% | 2144 |
|
|
2016
Q1 | $36K | Buy |
12,639
+322
| +3% | +$1.43K | ﹤0.01% | 2135 |
|
|
2015
Q4 | $127K | Hold |
12,317
| – | – | ﹤0.01% | 2092 |
|
|
2015
Q3 | $140K | Buy |
12,317
+2,247
| +22% | +$30K | ﹤0.01% | 2074 |
|
|
2015
Q2 | $150K | Sell |
10,070
-6,407
| -39% | -$72.8K | ﹤0.01% | 2085 |
|
|
2015
Q1 | $149K | Sell |
16,477
-2,879
| -15% | -$29.8K | ﹤0.01% | 2060 |
|
|
2014
Q4 | $235K | Buy |
19,356
+789
| +4% | +$8.71K | ﹤0.01% | 2001 |
|
|
2014
Q3 | $182K | Buy |
18,567
+2,271
| +14% | +$27.8K | ﹤0.01% | 2050 |
|
|
2014
Q2 | $208K | Buy |
+16,296
| New | +$159K | ﹤0.01% | 2075 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC